Chapter 16. Chemical Modification of Antibodies for Cancer Chemotherapy

This publication has 56 references indexed in Scilit:

• Potent and specific killing of human malignant brain tumor cells by an anti-transferrin receptor antibody-ricin immunotoxin
  Journal of Neurosurgery, 1987
• Conjugation behaviour of different monoclonal antibodies to F-methionyl-leucyl-phenylalanine
  International Journal of Immunopharmacology, 1986
• Effect of methotrexate-albumin-monoclonal antibody conjugates on methotrexate-resistant cells
  European Journal of Cancer and Clinical Oncology, 1985
• Linker Technology: Antibody-Mediated Delivery Systems
  Bio/Technology, 1985
• Immunotoxins
  Trends in Biotechnology, 1985
• Biological activities of human recombinant interferon α/β targeted by anti‐Epstein‐Barr virus monoclonal antibodies
  FEBS Letters, 1985
• Preparation of four daunomycin‐monoclonal antibody 79IT/36 conjugates with anti‐tumour activity
  International Journal of Cancer, 1984
• Ricin B chain converts a non‐cytotoxic antibody‐ricin A chain conjugate into a potent and specific cytotoxic agent
  FEBS Letters, 1983
• Production of a monoclonal antibody-bleomycin conjugate utilizing dextran T-40 and the antigen-targeting cytotoxicity of the conjugate
  Biochemical and Biophysical Research Communications, 1983
• Biological activity of the antitumor protein neocarzinostatin coupled to a monoclonal antibody by N-succinimidyl 3-(2-pyridyldithio)-propionate
  Biochemical and Biophysical Research Communications, 1981